Dapagliflozin in Patients with Chronic Kidney Disease von Heerspink, Hiddo J.L, Stefánsson, Bergur V, Correa-Rotter, Ricardo, Chertow, Glenn M, Greene, Tom, Hou, Fan-Fan, Mann, Johannes F.E, McMurray, John J.V, Lindberg, Magnus, Rossing, Peter, Sjöström, C. David, Toto, Roberto D, Langkilde, Anna-Maria, Wheeler, David C

Volltext

Bariatric Surgery and Long-term Cardiovascular Events von Sjöström, Lars, Peltonen, Markku, Jacobson, Peter, Sjöström, C. David, Karason, Kristjan, Wedel, Hans, Ahlin, Sofie, Anveden, Åsa, Bengtsson, Calle, Bergmark, Gerd, Bouchard, Claude, Carlsson, Björn, Dahlgren, Sven, Karlsson, Jan, Lindroos, Anna-Karin, Lönroth, Hans, Narbro, Kristina, Näslund, Ingmar, Olbers, Torsten, Svensson, Per-Arne, Carlsson, Lena M. S

Volltext

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease von Chertow, Glenn M, Vart, Priya, Jongs, Niels, Toto, Robert D, Gorriz, Jose Luis, Hou, Fan Fan, McMurray, John J V, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C David, Stefánsson, Bergur V, Langkilde, Anna Maria, Wheeler, David C, Heerspink, Hiddo J L

Volltext

Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function von Petrykiv, Sergei, Sjöström, C David, Greasley, Peter J, Xu, John, Persson, Frederik, Heerspink, Hiddo J L

Volltext

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study von Fioretto, Paola, Del Prato, Stefano, Buse, John B., Goldenberg, Ronald, Giorgino, Francesco, Reyner, Daniel, Langkilde, Anna Maria, Sjöström, C. David, Sartipy, Peter

Volltext

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy von Wheeler, David C., Toto, Robert D., Stefánsson, Bergur V., Jongs, Niels, Chertow, Glenn M., Greene, Tom, Hou, Fan Fan, McMurray, John J.V., Pecoits-Filho, Roberto, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C. David, Umanath, Kausik, Langkilde, Anna Maria, Heerspink, Hiddo J.L.

Volltext

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-... von Wheeler, David C, Stefánsson, Bergur V, Jongs, Niels, Chertow, Glenn M, Greene, Tom, Hou, Fan Fan, McMurray, John J V, Correa-Rotter, Ricardo, Rossing, Peter, Toto, Robert D, Sjöström, C David, Langkilde, Anna Maria, Heerspink, Hiddo J L

Volltext

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects von Sjöström, C. David, Sjöström, Lars, Narbro, Kristina, Karason, Kristjan, Larsson, Bo, Wedel, Hans, Lystig, Ted, Sullivan, Marianne, Bouchard, Claude, Carlsson, Lena M.S, Carlsson, Björn, Bengtsson, Calle, Dahlgren, Sven, Gummesson, Anders, Jacobson, Peter, Karlsson, Jan, Lindroos, Anna-Karin, Lönroth, Hans, Näslund, Ingmar, Olbers, Torsten, Stenlöf, Kaj, Torgerson, Jarl, Ågren, Göran

Volltext

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diab... von Pollock, Carol, Stefánsson, Bergur, Reyner, Daniel, Rossing, Peter, Sjöström, C David, Wheeler, David C, Langkilde, Anna Maria, Heerspink, Hiddo J L

Volltext

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial von Sjöström, Lars, Prof, Dr, Gummesson, Anders, MD, Sjöström, C David, MD, Narbro, Kristina, PhD, Peltonen, Markku, PhD, Wedel, Hans, Prof, Bengtsson, Calle, Prof, Bouchard, Claude, Prof, Carlsson, Björn, Prof, Dahlgren, Sven, Prof, Jacobson, Peter, MD, Karason, Kristjan, MD, Karlsson, Jan, PhD, Larsson, Bo, MD, Lindroos, Anna-Karin, PhD, Lönroth, Hans, MD, Näslund, Ingmar, MD, Olbers, Torsten, MD, Stenlöf, Kaj, MD, Torgerson, Jarl, MD, Carlsson, Lena MS, Prof

Volltext

Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes von Tang, Li, Wu, Yuanyuan, Tian, Mi, Sjöström, C David, Johansson, Ulrika, Peng, Xiao-Rong, Smith, David M, Huang, Yufeng

Volltext

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics von Wheeler, David C, Stefansson, Bergur V, Batiushin, Mikhail, Bilchenko, Oleksandr, Cherney, David Z I, Chertow, Glenn M, Douthat, Walter, Dwyer, Jamie P, Escudero, Elizabeth, Pecoits-Filho, Roberto, Furuland, Hans, Górriz, José Luis, Greene, Tom, Haller, Hermann, Hou, Fan Fan, Kang, Shin-Wook, Isidto, Rey, Khullar, Dinesh, Mark, Patrick B, McMurray, John J V, Kashihara, Naoki, Nowicki, Michal, Persson, Frederik, Correa-Rotter, Ricardo, Rossing, Peter, Toto, Robert D, Umanath, Kausik, Van Bui, Pham, Wittmann, István, Lindberg, Magnus, Sjöström, C David, Langkilde, Anna Maria, Heerspink, Hiddo J L

Volltext

Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment von Fioretto, Paola, Stefansson, Bergur V., Johnsson, Eva, Cain, Valerie A., Sjöström, C. David

Volltext

Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese... von Lundkvist, Per, Sjöström, C. David, Amini, Sam, Pereira, Maria J., Johnsson, Eva, Eriksson, Jan W.

Volltext

Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic... von Wheeler, David C, Jongs, Niels, Stefansson, Bergur V, Chertow, Glenn M, Greene, Tom, Hou, Fan Fan, Langkilde, Anna Maria, McMurray, John J V, Rossing, Peter, Nowicki, Michal, Wittmann, István, Correa-Rotter, Ricardo, Sjöström, C David, Toto, Robert D, Heerspink, Hiddo J L

Volltext

Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial von Jongs, Niels, Greene, Tom, Chertow, Glenn M, McMurray, John J V, Langkilde, Anna Maria, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C David, Stefansson, Bergur V, Toto, Robert D, Wheeler, David C, Heerspink, Hiddo J L

Volltext

Once-Weekly Exenatide in Youth With Type 2 Diabetes von Tamborlane, William V, Bishai, Raafat, Geller, David, Shehadeh, Naim, Al-Abdulrazzaq, Dalia, Vazquez, Evelina Mánica, Karoly, Eva, Troja, Tünde, Doehring, Orlando, Carter, Debra, Monyak, John, Sjöström, C David

Volltext

Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease von McMurray, John J.V., Wheeler, David C., Stefánsson, Bergur V., Jongs, Niels, Postmus, Douwe, Correa-Rotter, Ricardo, Chertow, Glenn M., Greene, Tom, Held, Claes, Hou, Fan-Fan, Mann, Johannes F.E., Rossing, Peter, Sjöström, C. David, Toto, Roberto D., Langkilde, Anna Maria, Heerspink, Hiddo J.L.

Volltext

Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CK... von Heerspink, Hiddo J L, Jongs, Niels, Chertow, Glenn M, Langkilde, Anna Maria, McMurray, John J V, Correa-Rotter, Ricardo, Rossing, Peter, Sjöström, C David, Stefansson, Bergur V, Toto, Robert D, Wheeler, David C, Greene, Tom

Volltext

Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease von Dekkers, Claire C J, Wheeler, David C, Sjöström, C David, Stefansson, Bergur V, Cain, Valerie, Heerspink, Hiddo J L

Volltext